Blog
RSS FeedPosted by Michael Wonder on 19 Dec 2018
NICE authorises MSD's Keytruda for stage III melanoma
19 December 2018 - MSD’s Keytruda has been given a green light for use within the EU as an adjuvant ...
Posted by Michael Wonder on 19 Dec 2018
NICE appraisal fees to be introduced despite opposition
14 December 2018 - Concessions made for small companies. ...
Posted by Michael Wonder on 13 Dec 2018
Brexit contributes to surge in generic drug prices
13 December 2018 - Calls for government to protect pharmacies. ...
Posted by Michael Wonder on 12 Dec 2018
NICE says no to rival Alnylam and Akcea amyloidosis drugs – but deal could be done
12 December 2018 - Room for manoeuvre after initial rejection. ...
Posted by Michael Wonder on 12 Dec 2018
New NICE standards to improve digital health tech uptake
12 December 2018 - NICE has published new standards setting out the requirements needed to develop digital health technologies for ...
Posted by Michael Wonder on 10 Dec 2018
NICE turns down Opdivo/Yervoy combo for kidney cancer
10 December 2018 - NICE has published draft guidelines rejecting NHS funds for Opdivo/Yervoy for untreated metastatic renal cell carcinoma. ...
Posted by Michael Wonder on 10 Dec 2018
Pharma calls for more detail on plan for post Brexit medicines access
10 December 2018 - The pharmaceutical industry is calling on the government to urgently provide more detail on how it ...
Posted by Michael Wonder on 07 Dec 2018
NICE OKs NHS funding for Gilead’s CAR T-cell therapy
7 December 2018 - Gilead’s CAR T-cell therapy Yescarta will be available on the NHS to some adults with lymphoma. ...
Posted by Michael Wonder on 05 Dec 2018
NICE terminates two appraisals
5 December 2018 - NICE is unable to make a recommendation about the use of two medicines in the NHS because ...
Posted by Michael Wonder on 05 Dec 2018
NHS to save £1 billion on its medicines bill in 2019
5 December 2018 - The NHS is expected to save around £930 million on its medicines bill across the UK ...
Posted by Michael Wonder on 04 Dec 2018
Flexibility on cancer drugs approval will foster innovation
4 December 2018 - Between 2000 and 2016, no new drugs were approved for cancers of the brain, and there were ...
Posted by Michael Wonder on 04 Dec 2018
New cancer drugs taking longer to reach NHS patients
4 December 2018 - NHS patients are waiting longer for new cancer drugs because of delays in taking them through ...
Posted by Michael Wonder on 04 Dec 2018
NICE backs Cimzia for psoriasis, but rejects Ilumetri
4 December 2018 - Cost watchdog NICE has backed NHS funding for UCB’s Cimzia as a treatment for psoriasis, but ...
Posted by Michael Wonder on 30 Nov 2018
NICE U turn on Opdivo for skin cancer recurrence
30 November 2018 - NHS use of Bristol-Myers Squibb’s Opdivo to cut the risk of early stage skin cancer recurrence ...
Posted by Michael Wonder on 29 Nov 2018
Life extending treatment for patients with advanced liver cancer recommended by NICE
29 November 2018 - Approving regorafenib is a "welcome step forward" for those people who are eligible. ...